Pediatric Lymphatics Review: Current State and Future Directions

Pediatric lymphatic flow disorders present a unique disease spectrum with specific challenges and considerations. The immense recent advances in lymphatic imaging and therapeutics have allowed the identification and treatment of these devastating symptoms from the neonatal period to adolescence. The development of dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) has provided accurate diagnoses and classification of neonatal and pediatric flow disorders. The concomitant innovation in the field of lymphatic interventions including thoracic duct (TD) embolization, interstitial embolization, and lymphovenous anastomosis offers curative interventions. As the field rapidly grows, there is a need for both classification and treatment algorithms for these diseases.

This article describes the pediatric-specific lymphatic pathologies and technical considerations of treatment and diagnosis of lymphatic flow disorder.

Publikationsverlauf

Artikel online veröffentlicht:
01. Oktober 2020

• References

• 1 Bellini C, Ergaz Z, Radicioni M. , et al. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study. Lymphology 2012; 45 (03) 91-102
• 2 Hori Y, Ozeki M, Hirose K. , et al. Analysis of mTOR pathway expression in lymphatic malformation and related diseases. Pathol Int 2020; 70 (06) 323-329
• 3 Itkin M, Nadolski GJ. Modern techniques of lymphangiography and interventions: current status and future development. Cardiovasc Intervent Radiol 2018; 41 (03) 366-376
• 4 Itkin M. Interventional treatment of pulmonary lymphatic anomalies. Tech Vasc Interv Radiol 2016; 19 (04) 299-304
• 5 Biko DM, Johnstone JA, Dori Y, Victoria T, Oliver ER, Itkin M. Recognition of neonatal lymphatic flow disorder: fetal MR findings and postnatal MR lymphangiogram correlation. Acad Radiol 2018; 25 (11) 1446-1450
• 6 Gray M, Kovatis KZ, Stuart T. , et al. Treatment of congenital pulmonary lymphangiectasia using ethiodized oil lymphangiography. J Perinatol 2014; 34 (09) 720-722
• 7 Rajebi MR, Chaudry G, Padua HM. , et al. Intranodal lymphangiography: feasibility and preliminary experience in children. J Vasc Interv Radiol 2011; 22 (09) 1300-1305
• 8 Kim J, Won JH. Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol 2016; 19 (04) 291-298
• 9 Majdalany BS, Khayat M, Downing T. , et al. Lymphatic interventions for isolated, iatrogenic chylous ascites: a multi-institution experience. Eur J Radiol 2018; 109: 41-47
• 10 Nadolski GJ, Chauhan NR, Itkin M. Lymphangiography and lymphatic embolization for the treatment of refractory chylous ascites. Cardiovasc Intervent Radiol 2018; 41 (03) 415-423
• 11 Srinivasa RN, Chick JFB, Gemmete JJ, Hage AN, Srinivasa RN. Endolymphatic interventions for the treatment of chylothorax and chylous ascites in neonates: technical and clinical success and complications. Ann Vasc Surg 2018; 50: 269-274
• 12 Trenor III CC, Chaudry G. Complex lymphatic anomalies. Semin Pediatr Surg 2014; 23 (04) 186-190
• 13 Iacobas I, Adams DM, Pimpalwar S. , et al. Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies-expert opinion consensus. Pediatr Blood Cancer 2020; 67 (01) e28036
• 14 Atton G, Gordon K, Brice G. , et al. The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review. Eur J Hum Genet 2015; 23 (12) 1634-1639
• 15 Biko DM, Reisen B, Otero HJ. , et al. Imaging of central lymphatic abnormalities in Noonan syndrome. Pediatr Radiol 2019; 49 (05) 586-592
• 16 Savla J, Itkin M, Rossano JW, Dori Y. Utilization of magnetic resonance lymphangiography to determine the etiology of chylothorax and predict the outcome of lymphatic embolization in patients with congenital heart disease. Circulation 2018; 134 (Suppl. 01) A17065-A17065
• 17 Reisen B, Kovach SJ, Levin LS. , et al. Thoracic duct-to-vein anastomosis for the management of thoracic duct outflow obstruction in newborns and infants: a CASE series. J Pediatr Surg 2020; 55 (02) 234-239
• 18 Weissler JM, Cho EH, Koltz PF. , et al. Lymphovenous anastomosis for the treatment of chylothorax in infants: a novel microsurgical approach to a devastating problem. Plast Reconstr Surg 2018; 141 (06) 1502-1507
• 19 Ozeki M, Nozawa A, Yasue S. , et al. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies. Orphanet J Rare Dis 2019; 14 (01) 141
• 20 Li D, March ME, Gutierrez-Uzquiza A. , et al. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nat Med 2019; 25 (07) 1116-1122
• 21 Goyal P, Alomari AI, Kozakewich HP. , et al. Imaging features of kaposiform lymphangiomatosis. Pediatr Radiol 2016; 46 (09) 1282-1290
• 22 Itkin M, Rabinowitz DA, Nadolski G, Stafler P, Mascarenhas L, Adams D. Abnormal pulmonary lymphatic flow in patients with lymphatic anomalies and respiratory compromise. Chest 2020; 158 (02) 681-691
• 23 Itkin M, Nadolski G, Rabinowitz D. Lymphatic embolization of abnormal pulmonary lymphatic flow in patients with lymphatic malformations. Presented at the: ISSVA; May 14, 2020. Available at: https://www.issva.org/online-workshop-2020/scientific-program/thursday-schedule . Accessed August 1, 2020
• 24 Caruthers RL, Kempa M, Loo A. , et al. Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis. Pediatr Cardiol 2013; 34 (02) 256-261
• 25 Rychik J, Atz AM, Celermajer DS. , et al; American Heart Association Council on Cardiovascular Disease in the Young and Council on Cardiovascular and Stroke Nursing.. Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation 2019; 140 (06)
• 26 Madsen P, Shah SA, Rubin BK. Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 2005; 6 (04) 292-300
• 27 Laubisch JE, Green DM, Mogayzel PJ, Reid Thompson W. Treatment of plastic bronchitis by orthotopic heart transplantation. Pediatr Cardiol 2011; 32 (08) 1193-1195
• 28 Itkin M, Pizarro C, Radtke W, Spurrier E, Rabinowitz DA. Lymphatic management in single-ventricle patients. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2020; 23: 41-47
• 29 Dori Y, Keller MS, Rome JJ. , et al. Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease. Circulation 2016; 133 (12) 1160-1170
• 30 Itkin M, Piccoli DA, Nadolski G. , et al. Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol 2017; 69 (24) 2929-2937
• 31 Levitt DG, Levitt MD. Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol 2017; 10: 147-168
• 32 Florent C, L'Hirondel C, Desmazures C, Aymes C, Bernier JJ. Intestinal clearance of α 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology 1981; 81 (04) 777-780